Cargando…

Impact of COVID-19 on healthcare organisation and cancer outcomes

BACKGROUND: Changes in the management of patients with cancer and delays in treatment delivery during the COVID-19 pandemic may impact the use of hospital resources and cancer mortality. PATIENTS AND METHODS: Patient flows, patient pathways and use of hospital resources during the pandemic were simu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bardet, Aurelie, Fraslin, Alderic M., Marghadi, Jamila, Borget, Isabelle, Faron, Matthieu, Honoré, Charles, Delaloge, Suzette, Albiges, Laurence, Planchard, David, Ducreux, Michel, Hadoux, Julien, Colomba, Emeline, Robert, Caroline, Bouhir, Samia, Massard, Christophe, Micol, Jean-Baptiste, Ter-Minassian, Lucile, Michiels, Stefan, Auperin, Anne, Barlesi, Fabrice, Bonastre, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213441/ https://www.ncbi.nlm.nih.gov/pubmed/34153714 http://dx.doi.org/10.1016/j.ejca.2021.05.012

Ejemplares similares

Un modèle de micro-simulation à événements discrets pour estimer les impacts de l’épidémie de COVID-19 sur l’organisation des soins et la mortalité par cancer
por: Fraslin, A., et al.
Publicado: (2021)

Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer
por: Giudici, Fabiola, et al.
Publicado: (2023)

Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions
por: Rassy, Elie, et al.
Publicado: (2022)

Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
por: Pommeret, F., et al.
Publicado: (2021)

ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer
por: Fizazi, Karim, et al.
Publicado: (2015)

Tumor cell malignancy: A complex trait built through reciprocal interactions between tumors and tissue-body system
por: Feunteun, Jean, et al.
Publicado: (2022)

Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
por: Lavaud, Pernelle, et al.
Publicado: (2020)

Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinoma
por: Guida, Annalisa, et al.
Publicado: (2020)

1617P Sustained cancer clinical trial activity during the COVID-19 pandemic
por: Bayle, A., et al.
Publicado: (2021)

Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic
por: Bayle, Arnaud, et al.
Publicado: (2021)

Impact of Competition Versus Centralisation of Hospital Care on Process Quality: A Multilevel Analysis of Breast Cancer Surgery in France
por: Or, Zeynep, et al.
Publicado: (2020)

Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience
por: Touloupas, Caroline, et al.
Publicado: (2021)

Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer
por: Chaput, N, et al.
Publicado: (2013)

Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
por: Lueza, Béranger, et al.
Publicado: (2016)

Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
por: Lueza, Béranger, et al.
Publicado: (2016)

Severe COVID-19 in patients with hematological cancers presenting with viremia
por: Michot, J.M., et al.
Publicado: (2021)

Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report
por: Aldea, Mihaela, et al.
Publicado: (2022)

Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohort
por: Antoine, Alison, et al.
Publicado: (2023)

Clinical development of mTOR inhibitors in breast cancer
por: Vicier, Cecile, et al.
Publicado: (2014)

Utilization of a training portfolio in thoracic and cardiovascular surgery: the example of the French platform-EPIFORM
por: Fourdrain, Alex, et al.
Publicado: (2021)

Oral available agents in the treatment of RRMS
por: Aupérin, Thierry
Publicado: (2013)

Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma
por: Colomba, Emeline, et al.
Publicado: (2022)

Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project
por: Ezzalfani, Monia, et al.
Publicado: (2021)

Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients
por: Cabel, Luc, et al.
Publicado: (2017)

A microsimulation model to assess the economic impact of immunotherapy in non-small cell lung cancer
por: Legoupil, Clémence, et al.
Publicado: (2020)

Correction to: Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series
por: de Nattes, Tristan, et al.
Publicado: (2020)

Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology
por: Texier, Matthieu, et al.
Publicado: (2018)

Therapeutic vaccines for breast cancer: Has the time finally come?
por: Corti, Chiara, et al.
Publicado: (2022)

Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer
por: Carbonnier, Vincent, et al.
Publicado: (2023)

High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer
por: Pailler, E., et al.
Publicado: (2015)

ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
por: Hartl, Dana, et al.
Publicado: (2023)

Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
por: Hartl, Dana, et al.
Publicado: (2023)

1639P Impact of COVID-19 on ongoing oncological and hematological treatment strategy
por: Bayle, A., et al.
Publicado: (2021)

Impact of COVID-19 Pandemic on Cancer Research
por: Zon, Leonard, et al.
Publicado: (2020)

A major genetic accelerator of cancer diagnosis: rs867228 in FPR1
por: Sztupinszki, Zsofia, et al.
Publicado: (2021)

SARS-CoV-2 vaccines for cancer patients: a call to action
por: Corti, Chiara, et al.
Publicado: (2021)

Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease
por: Herrera-Gómez, Ruth Gabriela, et al.
Publicado: (2022)

Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study
por: Guillaume, Zoé, et al.
Publicado: (2022)

Loco-Regional Therapies in Oligometastatic Adrenocortical Carcinoma
por: Roux, Charles, et al.
Publicado: (2022)

Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up
por: Veron, Lucie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n6np9hv4tfriqvqoskcs3m79if